Knight (GUD) & Titan (TMD): 2 TSX cheap healthcare stocks to consider

Follow us on Google News:
 Knight (GUD) & Titan (TMD): 2 TSX cheap healthcare stocks to consider
Image source: © 2022 Kalkine Media Inc

Highlights

  • China might be battling a COVID resurgence, which may cause some investors to look for quality healthcare stocks
  • Knight Therapeutics Inc (TSX: GUD) and Titan Medical Inc (TSX: TMD), on Thursday, March 24, released their fourth-quarter and full-year results for fiscal 2021
  • Titan Medical expanded its portfolio to over 200 patents and applications in 2021

China might be battling a COVID resurgence, which may cause some investors to look for quality healthcare stocks.

Knight Therapeutics Inc (TSX: GUD) and Titan Medical Inc (TSX: TMD), on Thursday, March 24, released their fourth-quarter and full-year results for fiscal 2021.

Let us look at these two TSX healthcare stocks and their overall performance.

Knight Therapeutics Inc (TSX:GUD)

Knight Therapeutics increased its revenue to C$ 58.27 million in Q4 FY2021 compared to C$ 55.19 million a year ago. Meanwhile, the drug manufacturer saw its 2021 revenue reach C$ 243.47 million, up from C$ 199.51 million in 2020.

The small-cap company incurred a net loss of C$ 8.3 million in the latest quarter compared to a profit of C$ 8.23 million in Q4 2020. Its yearly net profit shrank to C$ 15.67 million in 2021, down from C$ 31.76 million.

The GUD stock closed at C$ 5.22 apiece on Thursday, March 24, down by over six per cent. The healthcare stock jumped by nearly five per cent in the last 12 months.

Knight Therapeutics Inc (TSX: GUD)’s Q4 FY2021 results

Also read: MDRN & NVAX: 2 COVID stocks as Canada plans to scrap pre-arrival test

Titan Medical Inc (TSX:TMD)

Titan Medical, a medical device firm engaged in developing surgical technologies, reported C$ 32.3 million in cash and cash equivalents as of December 31, 2021, up from C$ 25.5 million recorded a year ago. The medical instrument maker expanded its portfolio to over 200 patents and applications in 2021.

The TMD stock increased by almost six per cent week-to-date (WTD) and closed at C$ 0.73 apiece on Thursday.

Also read: Boyd Group (BYD) stock spikes 12% after Q4 sales growth. A buy?

Bottom line

Some medical stocks might help diversify an investment portfolio and provide exposure to new changes and developments in the healthcare industry. However, investors should make investment calls based on their market knowledge and interests keeping in mind the company’s financials and prospects.

Please note, the above content constitutes a very preliminary observation based on the industry, and is of limited scope without any in-depth fundamental valuation or technical analysis. Any interest in stocks or sectors should be thoroughly evaluated taking into consideration the associated risks.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Featured Articles

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK